Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2559750rdf:typepubmed:Citationlld:pubmed
pubmed-article:2559750lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C1325725lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C0020205lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C1413246lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C1826471lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C1837441lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:2559750lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:2559750pubmed:issue11lld:pubmed
pubmed-article:2559750pubmed:dateCreated1990-3-16lld:pubmed
pubmed-article:2559750pubmed:abstractTextThe self-assembly properties of a protein encoded by the yeast retrotransposon Ty can be exploited to produce large amounts of recombinant, particulate fusion proteins as hybrid Ty virus-like particles (Ty-VLPs). This system has now been adapted to allow the release of the additional protein by incorporation of a protease cleavage site between the yeast carrier protein and the protein of interest. The purification of the additional protein is facilitated by exploiting the ease with which Ty-VLPs can be purified from other yeast cell components due to their particulate nature. We have used this modified system to produce hybrid particles containing the HIV-1 p24 protein downstream of the recognition sequence for the blood coagulation factor Xa. The p24 was released from the particles by proteolytic cleavage and rapidly separated from the residual particulate material using centrifugation and standard chromatography techniques. This procedure has been used to purify milligram quantities of HIV-1 p24 protein that reacts with anti-p24 sera and elicits the production of p24-specific antibodies in experimental animals.lld:pubmed
pubmed-article:2559750pubmed:languageenglld:pubmed
pubmed-article:2559750pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:citationSubsetIMlld:pubmed
pubmed-article:2559750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2559750pubmed:statusMEDLINElld:pubmed
pubmed-article:2559750pubmed:monthNovlld:pubmed
pubmed-article:2559750pubmed:issn0269-9370lld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:EsnoufM PMPlld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:GuldCClld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:KingsmanA JAJlld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:KingsmanS MSMlld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:BuellI MIMlld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:AdamsS ESElld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:SeniorJ MJMlld:pubmed
pubmed-article:2559750pubmed:authorpubmed-author:GilmourJ EJElld:pubmed
pubmed-article:2559750pubmed:issnTypePrintlld:pubmed
pubmed-article:2559750pubmed:volume3lld:pubmed
pubmed-article:2559750pubmed:ownerNLMlld:pubmed
pubmed-article:2559750pubmed:authorsCompleteYlld:pubmed
pubmed-article:2559750pubmed:pagination717-23lld:pubmed
pubmed-article:2559750pubmed:dateRevised2006-4-21lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:meshHeadingpubmed-meshheading:2559750-...lld:pubmed
pubmed-article:2559750pubmed:year1989lld:pubmed
pubmed-article:2559750pubmed:articleTitleA novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs).lld:pubmed
pubmed-article:2559750pubmed:affiliationBritish Bio-technology Ltd., Cowley, UK.lld:pubmed
pubmed-article:2559750pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2559750lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2559750lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2559750lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2559750lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2559750lld:pubmed